The global animal parasiticides market, valued at US$ 6.2 billion in 2021, is projected to reach US$ 7.9 billion in 2022 and grow at a CAGR of 6.6%, reaching US$ 13.6 billion by 2032. Driven by rising animal health awareness, expanding livestock populations, and technological advancements, the market sees strong demand for ectoparasiticides, which held a 52% share in 2021. North America leads with a 6.5% CAGR, while Asia Pacific grows at 6.2% CAGR, fueled by pet adoption and meat demand. This report analyzes market dynamics, segments, regional insights, and trends through 2032.

For More Insights, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4316

Market Analysis

The animal parasiticides market is propelled by increasing zoonotic disease concerns, rising pet ownership, and demand for high-quality animal-derived food. Ectoparasiticides, addressing external parasites like ticks and fleas, dominate with a 52% share and a 6.3% CAGR, driven by their role in preventing human transmission. Innovations like Zoetis’ Simparica TrioTM (FDA-approved in 2020) and Merck’s SPHEREON technology enhance efficacy. Challenges include high product costs and limited rural awareness. Government funding, such as the EU’s US$ 2.2 billion for animal care (2014–2020), and R&D investments support growth.

Segment Analysis

Segmented by product and species, ectoparasiticides (oral tablets, sprays, spot-on) lead with a 6.3% CAGR, followed by endoparasiticides (injectables, feed additives) and endectocides. Companion animals, with US$ 1.8 billion spent in 2021, grow at a 6.1% CAGR, driven by 67% of U.S. households owning pets (APPA data). Food-producing animals, including cattle and poultry, also contribute significantly due to rising meat and dairy demand. Innovations in delivery systems, like Eupraxia’s sustained-release medications, enhance treatment efficacy, boosting market growth across both segments.

Country-wise Insights

North America, led by the U.S. (projected US$ 1.5 billion by 2032, 6.5% CAGR), dominates due to high pet ownership, R&D, and regulations from the USDA’s Animal and Plant Health Inspection Service. Asia Pacific, valued at US$ 3.1 billion by 2026 with a 6.2% CAGR, grows rapidly due to pet adoption and demand for animal byproducts in India (US$ 265 million in 2021) and China. Europe benefits from funding and awareness, while Latin America and MEA are emerging markets driven by improving veterinary infrastructure.

Key Players

• Zoetis, Inc.
• Merck Animal Health
• Ceva Sante Animale
• Boehringer Ingelheim GmbH
• Elanco Animal Health
• Bayer AG
• Vetoquinol
• Virbac
• The Chanelle Group

Strategic Outlook and Industry Trends

Key players focus on R&D and acquisitions, such as Zoetis’ 2022 purchase of NewMetrica for quality-of-life tools and Ceva’s partnership with Mitsui in Japan. Trends include advanced formulations like sustained-release drugs and digital marketing to raise awareness. Rising pet ownership, zoonotic disease concerns, and demand for animal protein drive growth. Regulatory support and direct-to-consumer sales models, as adopted by Zoetis, enhance market reach. Innovations in biologics and sustainable practices will shape the market through 2032.

Segmentation of Animal Parasiticides Market

By Product Type:

• Ectoparasiticides
• Oral Tablets
• Dips
• Spray
• Spot-on
• Others
• Endoparasiticides
• Oral Suspension
• Injectable
• Feed Additives
• Others
• Endectocides

By Species:

• Food-Producing Animals
• Cattle
• Poultry
• Swine
• Others
• Companion Animals
• Dogs
• Felines
• Others
• Other Livestock

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com